Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Explore various work from home opportunities that can help you earn extra cash. Take advantage of these options to boost your income.
22,767 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Two Roundhill ETFs harness a 0DTE covered call strategy to deliver regular Friday payouts, but investors should weigh...
AI-led gains cool as a quintet of warning signs reappear, drawing parallels to the late-2000s Nasdaq run. Investors b...
CoreWeave has turbocharged its AI compute backlog ahead of a Nasdaq-100 debut, placing the stock under fresh scrutiny...
A 62-year-old retiree faces a tax decision as SpaceX posts a 37% pop. The choice between a Roth IRA and a taxable bro...
SpaceX kicked off a $25 billion bond offering just weeks after a historic $75 billion IPO, while its stock trades wel...
As AI-driven stocks wobble between skepticism and momentum, HSBC strategists say a turn in valuations could lift pric...
Choosing the right pharmaceutical ETF can feel like balancing income with growth. This guide compares VanEck's PPH an...
As July unfolds, investors are eyeing three powerful nuclear energy stocks as policy momentum and grid demand bolster...
A landmark agreement between Apple and Broadcom signals a major shift in chip strategy and domestic manufacturing. Th...
When fear hits and you're worried about market swings, the impulse to bail out is strong. History says the single wor...
Tesla faces a pivotal Q2 print as shares struggle in 2026. While deliveries rose, investors will be watching margins,...